Expanding Tier 2 Participation Reshapes India’s Trial Ecosystem The April 2026 edition of IndiaTrialPulse by StriderDCT highlighted continued momentum in India’s multi-site clinical trial landscape, with increasing geographic participation and diversified therapeutic focus. Built on insights from the Clinical Trials
Multi-Site Momentum and Therapeutic Diversification Shape India’s Research Landscape The Q1 2026 edition of IndiaTrialPulse by StriderDCT analyzed how India’s clinical trial ecosystem evolved between January and March 2026. The quarter reflected growing multi-site momentum, strong domestic research participation, and
CNS and Oncology Continue to Drive Multi-Site Momentum The February 2026 edition of IndiaTrialPulse by StriderDCT tracked emerging trends from multi-site trials registered on the Clinical Trials Registry of India (CTRI). Key Highlights What This Indicates
Tracking the Pulse of Clinical Trials in India IndiaTrialPulse is a monthly clinical trial intelligence initiative by StriderDCT designed to decode emerging trends across India’s evolving clinical research ecosystem.Built using insights from the Clinical Trials Registry of India (CTRI), IndiaTrialPulse
StriderDCT is pleased to share that it has signed a Memorandum of Understanding (MoU) with Artificial Brain to jointly develop Quantum-Powered AI solutions for Clinical Research. StriderDCT brings deep domain expertise in decentralized and technology-enabled clinical trials, with a strong
Traditional clinical trials rely on a ‘one-size-fits-all approach’, requiring participants to visit physical clinical trial sites. This visit is regardless of their location, mobility, or personal circumstances. This has proven to be a significant hurdle: While historical frameworks like the
StriderDCT is Now a CDSCO-approved Clinical Research Organization (CRO) StriderDCT is now officially registered as a Clinical Research Organization (CRO) under the Central Drugs Standard Control Organization (CDSCO)— the country’s apex regulatory body for clinical trials. This registration serves as
At StriderDCT, we recognize that clinical trials are far more than a collection of protocols, datasets, and timelines—they are fundamentally about the people they’re designed to serve. In line with this philosophy, our Co‑founder, Vijay Rajan, recently took part in
We’re excited to announce a new milestone. Strider DCT has been officially certified to ISO 9001:2015 Quality Management System standards for clinical trial services. This certification marks a significant step forward in our mission to deliver high-quality, reliable, and efficient
Clinical trials are tedious, time-consuming and require robust mechanisms for ensuring patient retention in the study. For patients, frequent visits to the study site results in loss of time, efforts as well as sometimes absenteeism at work. These are few of
